Genetic Technologies Limited
GNTLF
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.33M | -1.37M | -1.84M | -1.84M | -2.09M |
| Total Depreciation and Amortization | 20.90K | 21.50K | 83.80K | 83.60K | 50.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.29M | 1.32M | -197.40K | -197.00K | 734.10K |
| Change in Net Operating Assets | -- | -- | 90.80K | 90.60K | -- |
| Cash from Operations | -23.20K | -23.90K | -1.87M | -1.86M | -1.31M |
| Capital Expenditure | -2.30K | -2.40K | -1.60K | -1.60K | -9.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 139.00K | 142.90K | 9.80K | 9.70K | 38.50K |
| Cash from Investing | 136.70K | 140.50K | 8.20K | 8.20K | 29.30K |
| Total Debt Issued | -- | -- | 300.50K | 300.50K | -- |
| Total Debt Repaid | -152.20K | -152.20K | -88.00K | -88.00K | -86.40K |
| Issuance of Common Stock | 18.80K | 18.80K | 1.29M | 1.29M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -43.00K | -43.00K | -2.30K | -2.30K | -1.10K |
| Cash from Financing | -115.00K | -118.20K | 987.60K | 985.60K | -57.10K |
| Foreign Exchange rate Adjustments | -1.00K | -1.00K | -21.00K | -20.90K | -8.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.50K | -2.60K | -892.50K | -890.60K | -1.34M |